APA (7th ed.) Citation

Morath, C., Wei, C., Macher-Göppinger, S., Schwenger, V., Zeier, M., & Reiser, J. (2013). Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. American journal of therapeutics, 20(2), . https://doi.org/10.1097/MJT.0b013e3182811aca

Chicago Style (17th ed.) Citation

Morath, Christian, Changli Wei, Stephan Macher-Göppinger, Vedat Schwenger, Martin Zeier, and Jochen Reiser. "Management of Severe Recurrent Focal Segmental Glomerulosclerosis Through Circulating Soluble Urokinase Receptor Modification." American Journal of Therapeutics 20, no. 2 (2013). https://doi.org/10.1097/MJT.0b013e3182811aca.

MLA (9th ed.) Citation

Morath, Christian, et al. "Management of Severe Recurrent Focal Segmental Glomerulosclerosis Through Circulating Soluble Urokinase Receptor Modification." American Journal of Therapeutics, vol. 20, no. 2, 2013, https://doi.org/10.1097/MJT.0b013e3182811aca.